International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 185-192 doi: 10.5281/zenodo.16761959
Original Article
A Study of Outcome of Pattern of Diabetic Foot Ulcers Based on The Pedis Classification Scoring System
 ,
Published
July 28, 2025
Abstract

Background: Diabetic foot ulcers (DFUs) are a significant complication of diabetes mellitus and a major cause of non-traumatic lower limb amputations.

The PEDIS classification (Perfusion, Extent, Depth, Infection, Sensation) provides a structured scoring system for evaluating DFUs.

This study aims to evaluate the outcomes of DFUs using the PEDIS scoring system.

Methods: This prospective observational study was conducted at the Department of General Surgery, Travancore Medical College, over 18 months.

A total of 110 patients with clinically diagnosed DFUs were enrolled. Each patient was assessed using the PEDIS score at presentation and followed up for six months to assess outcomes (healed, non-healed, amputated, or dead).

Results: Of the 110 patients, 61 had low PEDIS scores (0–7), and 49 had high scores (8–12).

Patients with high PEDIS scores had a statistically significant longer duration of diabetes (p<0.001), greater prevalence of hypertension (p=0.042),

diabetic neuropathy (p<0.001), peripheral occlusive vascular disease (p<0.001), and critical limb ischemia (p<0.001).

Surgical interventions, including debridement and amputation, were more common in the high PEDIS group (p<0.001).

Healing time was significantly longer (3.71 ± 1.81 months vs. 2.16 ± 1.15 months, p<0.001), and the rate of healing was lower in the high PEDIS group (28.57% vs. 96.72%, p<0.001).

Conclusion: The PEDIS scoring system is an effective tool for predicting outcomes in DFU patients.

A high PEDIS score correlates with poorer outcomes, increased need for surgical intervention, and prolonged healing duration

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1330 Views
339 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved